SCHEMBL21856348

SCHEMBL21856348

COc1cc(N[C@@H]2CCN(C=CC=O)C2)cc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 1/20 0.40
▸ EPHX2 P34913 1/20 0.39
▸ GFER P55789 2/20 0.37
▸ HDAC3 O15379 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ RHOA P61586 1/20 0.35
▸ DPP4 P27487 2/20 0.35
▸ TMPRSS4 Q9NRS4 1/20 0.35
▸ CCR6 P51684 1/20 0.34
▸ BRAF P15056 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21856357 0.89 RHOC (0.40) EPHX2KMT2ARHOAUBE2MDCUN1D1
SCHEMBL21856326 0.83 RHOC (0.42) HDAC3HDAC1HDAC2HDAC6RHOA
SCHEMBL21856314 0.80 DDR1 (0.39) BRAFALDH1A1
SCHEMBL21856323 0.80 IDH2 (0.45) EPHX2KMT2AUBE2MDCUN1D1
SCHEMBL21856349 0.79 DDB1 (0.47) KMT2AALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL21856354 0.79 EGFR (0.39) RHOABRAFCYP3A4CYP2C9
SCHEMBL21856365 0.78 BRAF (0.36) RHOABRAF
SCHEMBL21958156 0.77 TEAD1 (0.53) EPHX2GFERKMT2A
SCHEMBL21856343 0.75 TAS2R14 (0.37) KMT2ANPSR1UBE2MDCUN1D1
SCHEMBL21856309 0.70 SPR (0.43) CCR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081572-A1 TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-04-23 — — WO disclosed
Send feedback